Form 4 for KYTX Kyverna Therapeutics, Inc.
Accepted 2026-03-17 00:00:00 ET · period of report 2026-03-13 · accession 0001193125-26-110934 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-17 | 2026-03-13 | KYTX | GRASSO MARC | CFO | A - Grant | $0.00 | +10.0K | 10.0K | New | $0 |
| D | 2026-03-17 | 2026-03-13 | KYTX | GRASSO MARC | CFO | A - Grant | $0.00 | +65.0K | 65.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-13 | A | A | 10,000 | $0.00 | 10,000 | D | — | — | (F1) Represents a restricted stock unit award of common stock and 1/4th of the shares underlying the restricted stock unit award shall vest on March 13, 2027 and an additional 1/4th of the shares underlying the restricted stock unit award shall vest on each one-year anniversary thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive. |
| 2 | Derivative | Stock Option (right to buy) | 2026-03-13 | A | A | 65,000 | $0.00 | 65,000 | D | $8.95 · — to 2036-03-13 | 65,000 Common Stock | (F2) 1/4th of the shares subject to the option shall vest on March 13, 2027 and an additional 1/48th of the shares subject to the option shall vest on the same day of each month thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive. |